Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Glucokinase Inhibition: A Novel Treatment for Diabetes?
Maria S. Remedi
,
Colin G. Nichols
Division of Endocrinology, Metabolism & Lipid Research
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Molecular Cell Biology
DBBS - Neurosciences
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Center for the Investigation of Membrane Excitability Diseases
Center of Regenerative Medicine
Department of Cell Biology & Physiology
DBBS - Biochemistry, Biophysics, and Structural Biology
Institute of Clinical and Translational Sciences (ICTS)
Hope Center for Neurological Disorders
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucokinase Inhibition: A Novel Treatment for Diabetes?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Treatments
100%
B Cells
100%
Diabetes
100%
Glucokinase
100%
Glycolysis
66%
Cell Mass
66%
Cell Loss
33%
Insulin Secretion
33%
Cellular Energy Metabolism
33%
Diabetes Management
33%
Pancreatic β-cells
33%
Glucotoxicity
33%
Targeted Inhibition
33%
Chronic Hyperglycemia
33%
Glucose Sensing
33%
Cell Failure
33%
Medicine and Dentistry
Diabetes
100%
Glucokinase
100%
Hyperglycemia
33%
Insulin Release
33%
Glucotoxicity
33%